Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUTICS INC | $629.06M | $0.00 | -$133.43M | -$134.04M | -$4.30 | N/A | N/A | N/A | N/A | |||
| TYRA | TYRA BIOSCIENCES INC | $1.77B | $0.00 | -$119.40M | -$119.95M | -$2.01 | N/A | N/A | N/A | N/A | |||
| KGC | KINROSS GOLD CORP | $36.32B | $7.96B | $5.13B | $2.87B | $2.36 | 43.07% | 14.18% | 140.82% | 16.49% | |||
| VKTX | VIKING THERAPEUTICS INC | $3.67B | $0.00 | -$471.93M | -$472.34M | -$4.15 | N/A | N/A | N/A | N/A | |||
| TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | N/A | $0.00 | -$163.66M | -$166.09M | N/A | N/A | N/A | N/A | N/A | |||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $155.83M | $70.00M | $22.69M | $22.37M | $0.39 | N/A | N/A | N/A | N/A | 2026-05-13 | ||
| GLUE | MONTE ROSA THERAPEUTICS INC | $1.59B | $123.67M | -$31.37M | -$38.63M | -$0.46 | 63.54% | N/A | N/A | N/A | |||
| BLLN | BILLIONTOONE INC | $4.27B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||
| LBRX | LB PHARMACEUTICALS INC | $917.02M | $0.00 | -$24.74M | -$25.21M | -$3.13 | N/A | N/A | N/A | N/A | 2026-05-15 | ||
| DNLI | DENALI THERAPEUTICS INC | $3.13B | $0.00 | -$497.63M | -$512.54M | -$2.97 | N/A | -100.00% | N/A | N/A | 2026-05-12 | ||
| NYXH | NYXOAH SA | $137.68M | $11.52M | -$83.99M | -$103.55M | -$2.72 | 150.31% | 168.71% | N/A | N/A | 2026-05-19 | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $217.54M | $364.78M | $102.58M | $25.04M | $0.84 | -0.19% | 11.47% | -17.65% | 83.84% | |||
| CLYM | CLIMB BIO INC | $681.97M | $0.00 | -$52.44M | -$52.79M | -$0.77 | N/A | N/A | N/A | N/A | |||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.34B | $0.00 | -$364.13M | -$377.94M | -$3.29 | N/A | -100.00% | N/A | N/A | |||
| VIST | VISTA ENERGY SAB DE CV | $6.92B | $2.90B | $2.05B | $743.98M | $7.09 | 63.99% | 55.75% | 41.38% | N/A | |||
| IDYA | IDEAYA BIOSCIENCES INC | $2.48B | $225.27M | -$135.46M | -$140.06M | -$1.58 | 3,118.14% | 53.10% | N/A | N/A | 2026-05-12 | ||
| CLSK | CLEANSPARK INC | $3.58B | $785.19M | $139.33M | -$267.04M | -$0.95 | 67.96% | 133.51% | N/A | N/A | |||
| EVER | EVERQUOTE INC | $728.69M | $716.74M | $80.89M | $109.99M | $3.04 | 24.49% | 14.18% | 181.48% | N/A | 2026-05-11 | ||
| SLDB | SOLID BIOSCIENCES INC | $695.63M | $0.00 | -$170.52M | -$174.33M | -$1.99 | N/A | N/A | N/A | N/A | |||
| PCVX | VAXCYTE INC | $7.43B | $0.00 | -$920.69M | -$946.53M | -$6.88 | N/A | N/A | N/A | N/A | |||
| CGEM | CULLINAN THERAPEUTICS INC | $890.94M | $0.00 | -$219.57M | -$220.56M | -$3.36 | N/A | N/A | N/A | N/A | |||
| SEPN | SEPTERNA INC | $1.08B | $45.95M | -$45.16M | -$48.88M | -$1.10 | 4,174.51% | N/A | N/A | N/A | 2026-05-14 | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $410.16M | $884.00k | -$100.29M | -$103.12M | -$1.40 | -39.20% | -38.32% | N/A | N/A | 2026-05-19 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.